References and Notes
<A NAME="RG38909ST-1A">1a</A>
Szmuszkovicz J.
Glenn EM.
Heinzelman RV.
Hester JB.
Youngdale GA.
J.
Med. Chem.
1966,
9:
527
<A NAME="RG38909ST-1B">1b</A>
El-Diwani H.
Nakkady SS.
Hishmat OH.
El-Shabrawy OA.
Mahmoud SS.
Pharmazie
1992,
47:
178
<A NAME="RG38909ST-1C">1c</A>
El-Diwani HI.
Shmeiss NAMM.
Saleh NM.
Pol. J. Chem.
1995,
69:
470
<A NAME="RG38909ST-1D">1d</A>
Shmeiss NAMM.
Ismail MMF.
El-Diwani HI.
Hassan AB.
Nada SA.
Modell.,
Meas. Control C
1997,
55:
11
<A NAME="RG38909ST-1E">1e</A>
Jones RL.
Qian Y.-M.
Wise H.
Wong HNC.
Lam W.-L.
Chan H.-W.
Yim APC.
Ho JKS.
J. Cardiovasc. Pharmacol.
1997,
29:
525
<A NAME="RG38909ST-1F">1f</A>
Hishmat OH.
Ebeid MY.
Nakkady SS.
Fathy MM.
Mahmoud SS.
Boll. Chim. Farm.
1999,
138:
259
<A NAME="RG38909ST-2A">2a</A>
Glenn EM.
Bowman BJ.
Kooyers W.
Koslowske T.
Myers ML.
J.
Pharmacol. Exp. Ther.
1967,
155:
157
<A NAME="RG38909ST-2B">2b</A>
Kaiser DG.
Glenn EM.
Johnson RH.
Johnston
RL.
J.
Pharmacol. Exp. Ther.
1967,
155:
174
<A NAME="RG38909ST-2C">2c</A>
Whitehouse MW.
J. Pharm. Pharmacol.
1967,
19:
590
<A NAME="RG38909ST-2D">2d</A>
Collier HOJ.
James GWL.
Piper PJ.
Br. J. Pharmacol.
1968,
34:
76
<A NAME="RG38909ST-2E">2e</A>
Brune K.
Graf P.
Glatt M.
Agents
Actions
1976,
6:
159
<A NAME="RG38909ST-2F">2f</A>
Podos SM.
Becker B.
Invest. Ophthalmol.
1976,
15:
841
<A NAME="RG38909ST-2G">2g</A>
Spinelli HM.
Krohn DL.
Arch.
Ophthalmol.
1980,
98:
1106
<A NAME="RG38909ST-2H">2h</A>
Klug RD.
Krohn DL.
Breitfeller JM.
Dieterich D.
Ophthalmic
Res.
1981,
13:
122
<A NAME="RG38909ST-3">3</A> For a recent study, see:
McAdam BF.
Catella-Lawson F.
Mardini IA.
Kapoor S.
Lawson JA.
FitzGerald GA.
Proc. Natl. Acad. Sci. U.S.A.
1999,
96:
272
<A NAME="RG38909ST-4">4</A> For a recent review of indole syntheses,
see:
Gribble GW.
J. Chem.
Soc., Perkin Trans. 1
2000,
1045
<A NAME="RG38909ST-5">5</A> Review:
Schröter S.
Stock C.
Bach T.
Tetrahedron
2005,
61:
2245
<A NAME="RG38909ST-6">6</A>
Dang TT.
Dang TT.
Rasool N.
Villinger A.
Langer P.
Adv.
Synth. Catal.
2009,
351:
1595
<A NAME="RG38909ST-7">7</A>
Dang TT.
Dang TT.
Ahmad R.
Reinke H.
Langer P.
Tetrahedron
Lett.
2008,
49:
1698
<A NAME="RG38909ST-8">8</A>
Dang TT.
Villinger A.
Langer P.
Adv.
Synth. Catal.
2008,
350:
2109
<A NAME="RG38909ST-9A">9a</A>
Ishikura M.
Kamada M.
Terashima M.
Synthesis
1984,
936
<A NAME="RG38909ST-9B">9b</A>
Yang Y.
Martin AR.
Synth. Commun.
1992,
22:
1757
<A NAME="RG38909ST-9C">9c</A>
Carrera GMJr.
Sheppard GS.
Synlett
1994,
93
<A NAME="RG38909ST-9D">9d</A>
Tidwell JH.
Peat AJ.
Buchwald
SL.
J. Org. Chem.
1994,
59:
7164
<A NAME="RG38909ST-9E">9e</A>
Banwell MG.
Bissett BD.
Busato S.
Cowden CJ.
Hockless DCR.
Holman JW.
Read RW.
Wu AW.
J.
Chem. Soc., Chem. Commun.
1995,
2551
<A NAME="RG38909ST-9F">9f</A>
Merlic CA.
McInnes
DM.
You Y.
Tetrahedron Lett.
1997,
38:
6787
<A NAME="RG38909ST-9G">9g</A>
Merlic CA.
McInnes DM.
Tetrahedron
Lett.
1997,
38:
7661
<A NAME="RG38909ST-9H">9h</A>
Moody CJ.
Doyle KJ.
Elliott MC.
Mowlem TJ.
J.
Chem. Soc., Perkin Trans. 1
1997,
2413
<A NAME="RG38909ST-9I">9i</A>
Chu L.
Fisher MH.
Goulet MT.
Wyvratt MJ.
Tetrahedron
Lett.
1997,
38:
3871
<A NAME="RG38909ST-9J">9j</A>
Carbonnelle A.-C.
González-Zamora EG.
Beugelmans R.
Roussi G.
Tetrahedron
Lett.
1998,
39:
4467
<A NAME="RG38909ST-9K">9k</A> For reactions of triflates,
see:
Chi SM.
Choi J.-K.
Yum EK.
Chi DY.
Tetrahedron
Lett.
2000,
41:
919
<A NAME="RG38909ST-9L">9l</A>
Joseph B.
Malapel B.
Mérour J.-Y.
Synth.
Commun.
1996,
26:
3289
<A NAME="RG38909ST-9M">9m</A>
Malapel-Andrieu B.
Mérour J.-Y.
Tetrahedron
1998,
54:
11079
<A NAME="RG38909ST-10">10</A>
Kawasaki I.
Yamashita M.
Ohta S.
Chem.
Pharm. Bull.
1996,
44:
1831
<A NAME="RG38909ST-11">11</A>
Hussain M.
Dang TT.
Langer P.
Synlett
2009,
1822
<A NAME="RG38909ST-12A">12a</A>
Liu Y.
Gribble GW.
Tetrahedron
Lett.
2000,
41:
8717
<A NAME="RG38909ST-12B">12b</A> For metal-halide
exchange, see:
Liu Y.
Gribble GW.
Tetrahedron Lett.
2002,
43:
7135
<A NAME="RG38909ST-13">13</A>
General Procedure
for the Synthesis of 3a-e and 4a-e
The
reaction was carried out in a pressure tube. A 1,4-dioxane solution
(4 mL) of 1, K3PO4,
Pd(PPh3)4, and arylboronic acid 2 was stirred at 110 ˚C or 70 ˚C
for 6 h or 8 h. After cooling to 20 ˚C, a sat.
aq solution of NH4Cl was added. The organic and the aqueous
layer were separated, and the latter was extracted with CH2Cl2.
The combined organic layers were dried (Na2SO4),
filtered, and the filtrate was concentrated in vacuo. The residue
was purified by flash chromatography (silica gel, heptanes).
<A NAME="RG38909ST-14">14</A>
2,3-Bis(4-ethylphenyl)-1-methyl-1
H
-indole (3c)
Starting with 1 (289
mg, 1.0 mmol), 2c (262 mg, 2.3 mmol), K3PO4 (446
mg, 2.1 mmol), Pd(PPh3)4 (3 mol%),
and 1,4-dioxane (4 mL), 3c was isolated
as a yellowish oil (291 mg, 86%). ¹H
NMR (300 MHz, CDCl3): δ = 1.01
(t, J = 7.5
Hz, 3 H, CH3), 1.05 (t, J = 7.5
Hz, 3 H, CH3), 2.40 (q, J = 7.5
Hz, 2 H, CH2), 2.48 (q, J = 7.5
Hz, 2 H, CH2), 3.42 (s, 3 H, NCH3), 6.90-6.96
(m, 3 H, ArH), 7.02-7.10 (m, 7 H, ArH), 7.25 (d, J = 8.2 Hz,
1 H, ArH), 7.51 (d, J = 7.8
Hz, 1 H, ArH). ¹³C NMR (75.47 MHz,
CDCl3): δ = 15.8
(CH3), 16.0 (CH3), 29.1 (CH2),
29.2 (CH2), 31.2 (CH3), 110.7 (CH), 115.4
(C), 120.0 (CH), 121.0 (CH), 123.0 (CH), 128.1 (C), 128.5 (2 CH),
128.7 (2CH), 130.3 (C), 130.6 (2 CH), 132.0 (2 CH), 133.7 (C), 138.3
(C), 138.4 (C), 142.0 (C), 144.9 (C). IR (ATR): ν = 3047
(w), 3022 (w), 2961 (s), 2928 (w), 1797 (w), 1765 (w), 1726 (w),
1519 (m), 1463 (s), 1362 (m), 1325 (m), 1257 (m), 1131 (w), 1115
(w), 1089 (m), 1060 (w), 1017 (m), 967 (w), 923 (w), 869 (m), 836
(s), 801 (w), 740 (s), 652 (w), 629 (m), 545 (m) cm-¹.
MS (EI, 70 eV):
m/z (%) = 340
(28) [M + 1]+, 339
(100) [M+], 324 (34), 309 (5),
294 (5), 281 (5), 278 (4), 146 (5). HRMS (EI): m/z calcd for
C25H25N [M+]:
339.19815; found: 339.197901.
<A NAME="RG38909ST-15">15</A>
3-Bromo-2-(3,4-dimethoxyphenyl)-1-methyl-1
H
-indole (4d)
Starting with 1 (289
mg, 1.0 mmol), 2i (200 mg, 1.1 mmol), K3PO4 (318
mg, 1.5 mmol), Pd(PPh3)4 (3 mol%),
and 1,4-dioxane (4 mL), 4d was isolated
as a yellowish solid (272 mg, 79%), mp 146-148 ˚C. ¹H
NMR (300 MHz, CDCl3): δ = 3.59
(s, 3 H, NCH3), 3.84 (s, 3 H, OCH3), 3.87
(s, 3 H, OCH3), 6.93-6.95 (m, 2 H, ArH), 7.11-7.27
(m, 4 H, ArH), 7.50-7.53 (m, 1 H, ArH). ¹³C
NMR (62.89 MHz, CDCl3): δ = 30.6
(CH3), 54.9 (OCH3), 55.0 (OCH3),
88.9 (C), 108.6 (CH), 109.9 (CH), 112.8 (CH), 118.2 (CH), 119.5
(CH), 121.7 (CH), 121.8 (C), 122.4 (CH), 126.1 (C), 135.7 (C), 137.0
(C), 147.8 (C), 148.4 (C). IR (ATR): ν = 3052
(w), 2960 (w), 2924 (w), 1607 (w), 1584 (w), 1502 (m), 1462 (m),
1445 (m), 1404 (w), 1379 (w), 1339 (w), 1317 (w), 1257 (s), 1239
(s), 1168 (m), 1136 (s), 1022 (s), 945 (m), 911 (w), 858 (m), 812
(m), 777 (w), 750 (s), 654 (m), 575 (w), 547 (w) cm-¹.
MS (EI, 70 eV): m/z (%) = 348
(18) [M + 1, 8¹Br]+,
347 (100) [M+, 8¹Br],
346 (19) [M + 1, 79Br]+,
345 (98) [M+, 79Br],
331 (3), 302 (5), 302 (5), 300(4), 267 (3), 251 (5), 223 (24), 180
(10), 152 (7), 102 (5), 89 (2).
HRMS (EI, 70 eV): m/z calcd for C17H16O2NBr [M+, 8¹Br]: 347.03385;
found: 347.033958; m/z calcd
for C17H16O2NBr [M+, 79Br]:
345.03589; found: 345.035679.
<A NAME="RG38909ST-16">16</A>
General procedure
for the synthesis of 5a-e
The reaction was carried
out in a pressure tube. To a dioxane suspension (4 mL) of 1 (215 mg, 0.75 mmol), Pd(PPh3)4 (3 mol%),
and Ar¹B(OH)2 (0.82 mmol) was added
K3PO4 (238 mg, 1.1 mmol), and the solution
was degassed by bubbling argon through the solution for 10 min.
The mixture was heated at 70 ˚C under argon atmosphere
for 6 h. The mixture was cooled to 20 ˚C. To the
solution was added Ar²B(OH)2 (0.90
mmol) and K3PO4 (238 mg, 1.1 mmol), and the solution
was degassed again. The reaction mixture was heated under argon
atmosphere for 8 h at 110 ˚C. After cooling to
20 ˚C, the solution was diluted with H2O
and extracted with CH2Cl2 (3 × 25
mL). The combined organic layers were dried (Na2SO4),
filtered, and the filtrate was concentrated in vacuo. The residue
was purified by flash chromatography (silica gel, heptanes).
<A NAME="RG38909ST-17">17</A>
2-(2,5-Dimethoxyphenyl)-1-methyl-3-phenyl-1
H
-indole (5a)
Starting with 1 (215
mg, 0.75 mmol), 2k (150 mg, 0.82 mmol), 2a (110 mg, 0.9 mmol), K3PO4 (488
mg, 2.3 mmol), Pd(PPh3)4 (4 mol%),
and 1,4-dioxane (4 mL), 5a was isolated
as a yellowish oil (177 mg, 69%). ¹H
NMR (250 MHz, CDCl3): δ = 3.40
(s, 3 H, NCH3), 3.44 (s, 3 H, OCH3), 3.52
(s, 3 H, OCH3), 6.54 (d, J = 3.1
Hz, 1 H, ArH), 6.77-6.82 (m, 1 H, ArH), 6.87-6.98
(m, 3 H, ArH), 7.04-7.18 (m, 5 H, ArH), 7.28 (d, J = 8.3 Hz,
1 H, ArH), 7.56 (d, J = 7.8 Hz,
1 H, ArH). ¹³C NMR (62.9 MHz, CDCl3): δ = 30.7 (NCH3),
55.9 (OCH3), 56.3 (OCH3), 110.5 (CH), 113.3 (CH),
115.7 (C), 115.8 (CH), 119.5 (CH), 119.8 (CH), 120.6 (CH), 122.5
(C), 122.6 (CH), 126.2 (CH), 127.7 (C), 129.0 (2 CH), 130.1 (2 CH),
135.7 (C), 136.7 (C), 138.1 (C), 153.7 (C), 154.4 (C). IR (ATR): ν = 3051
(w), 2936 (w), 2832 (w), 1736 (w), 1712 (w), 1602 (w), 1549 (w),
1502 (m), 1485 (m), 1463 (m), 1366 (m), 1273 (m), 1225 (m), 1210
(m), 1039 (m), 1020 (m), 941 (w), 918 (w), 876 (w), 805 (w), 772 (m),
735 (s), 700 (s), 616 (w), 570 (w), 531 (w) cm-¹.
MS (EI, 70 eV): m/z (%) = 344
(26) [M + 1]+, 343
(100) [M+], 342 (15), 328
(6), 311 (4), 297 (7), 268 (5), 230 (5), 171 (4), 121 (5). HRMS
(EI, 70 eV): m/z calcd for C23H21O2N [M+]: 343.15668;
found: 343.156144.
<A NAME="RG38909ST-18">18</A>
Billingsley K.
Buchwald SL.
J. Am. Chem. Soc.
2007,
129:
3358 ; and references cited therein